See If You Qualify

Weight

Compounded Semaglutide vs Wegovy®

Two sisters cooking and laughing together in a home kitchen

General information, not medical advice · A medical provider licensed in your state makes every medical decision

See If You Qualify

Unlike Ozempic®, Wegovy® is the semaglutide brand the FDA actually approved for weight management — so if weight is your goal, this is the comparison that matters most. Here’s the honest breakdown of compounded semaglutide vs Wegovy®: what each is, their FDA status, and how the cost picture differs — without hype and without pretending they’re the same product.

The short answer

Wegovy® and compounded semaglutide are different products. Wegovy® is a commercially manufactured, FDA-approved brand-name medication for chronic weight management. Compounded semaglutide is a pharmacy-prepared medication that is not FDA-approved and is not a generic or a substitute for a branded product. They are not interchangeable.

What is Wegovy®?

Wegovy® is the semaglutide product the FDA approved specifically for weight: as the FDA describes it, “Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist,“[3] and it is approved to reduce excess weight and maintain weight reduction long term in certain adults with obesity or overweight. That’s the key difference from Ozempic®, which contains the same medication but is FDA-approved “as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus”[2] rather than for weight management.

What is compounded semaglutide?

Compounded semaglutide is a preparation of the medication semaglutide made by a state-licensed compounding pharmacy in an FDA-regulated facility for an individual patient, based on a prescription. The regulatory fact to understand up front: “Compounded drugs are not FDA-approved,“[1] and the FDA “does not verify the safety, effectiveness or quality of compounded drugs before they are marketed.”[1]

Compounded semaglutide vs Wegovy®: the honest comparison

  • Regulatory status. Wegovy® is FDA-approved and commercially manufactured. Compounded semaglutide is not FDA-approved and is prepared per-patient by a licensed pharmacy.[1]
  • What it’s approved for. Wegovy®‘s FDA-approved use is chronic weight management in certain adults.[3] A compounded preparation carries no such FDA approval.
  • Product identity. A compounded preparation is not a generic version of, or a substitute for, Wegovy®. We don’t claim it performs identically. A medical provider evaluates which category, if any, fits your history.

What about cost?

Brand-name GLP-1 medication is expensive without insurance. For context on brand cash pricing, Healthline notes that “Ozempic’s manufacturer, Novo Nordisk, usually offers the drug for $499 per month when you pay without insurance,“[4] and Wegovy® is priced in a similar premium range. Compounded options are priced differently because they aren’t branded products — in our program, every 4 weeks, with your exact price shown before anything is charged. We don’t quote a compounded preparation as “cheaper than” any brand.

Is compounded semaglutide safe or right for me?

Semaglutide is a GLP-1 receptor agonist with known side effects, and it isn’t right for everyone.[3] Because compounded medications are not FDA-approved, a responsible path means a licensed medical provider screens your history, confirms an option is appropriate, and monitors you. That clinical review is the real gate — not a checkout button.

A note for women weighing their options

Many women researching semaglutide are balancing metabolic health, hormonal shifts, and years of frustrating advice. Our role is honest information, not pressure. Medication is one tool among several, it isn’t right for everyone, and no product delivers a guaranteed outcome. If you’d like a medical provider to assess whether a compounded option is appropriate for you, start with our weight-wellness intake, where your history is reviewed first.

Sources

  1. 1FDA — Human Drug Compounding: Questions and Answers”Compounded drugs are not FDA-approved.”
  2. 2Ozempic (semaglutide) label — DailyMed”as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus”
  3. 3FDA News Release — Wegovy (semaglutide)“Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist.”
  4. 4Healthline — Ozempic Cost”For example, Ozempic’s manufacturer, Novo Nordisk, usually offers the drug for $499 per month when you pay without insurance.”

Free online consult · Provider review within 24–48 hours · 100% self-pay · Cancel any time

Reading is a good start. A real answer is better.

Whether GLP-1 treatment is appropriate for you is a medical decision, made by a licensed provider who has reviewed your actual health history. Finding out takes about 3–5 minutes and costs nothing.

See If You Qualify

Frequently asked questions

Is compounded semaglutide the same as Wegovy®?

No. Wegovy® is a commercially manufactured, FDA-approved brand-name product for chronic weight management. Compounded semaglutide is a separate, pharmacy-prepared medication that is not FDA-approved and is not a generic or substitute for a branded product. We never present a compounded preparation as equivalent to a branded medication.

Is Wegovy® the weight-loss version of semaglutide?

Wegovy® is the semaglutide product the FDA approved for chronic weight management in certain adults with obesity or overweight. Ozempic®, which also contains semaglutide, is approved for glycemic control in type 2 diabetes. A medical provider determines what, if anything, is appropriate for you.

Is compounded semaglutide FDA-approved?

No. Compounded drugs are not FDA-approved, and the FDA does not verify the safety, effectiveness, or quality of compounded drugs before they are marketed. They are prepared in FDA-regulated facilities by state-licensed pharmacies for an individual patient with a prescription.

How is compounded semaglutide priced compared to Wegovy®?

Compounded semaglutide is priced every 4 weeks and varies by dose and plan; your exact price is shown before anything is charged. Because it isn't a branded product, its pricing structure differs from brand options — we don't quote it as a discount off any brand. Ladies First provides marketing/advertising services. Medical services are provided by our medical provider partner, an independent network of US-licensed medical providers. All medical decisions are made by a medical provider licensed in your state. This article is general information, not medical advice. Individual results vary. Compounded medications are not FDA-approved; they are prepared in FDA-regulated facilities. Ozempic® and Wegovy® are registered trademarks of Novo Nordisk.

Reviewed against primary sources. Every clinical claim above is checked against FDA labeling, clinical-society guidelines, or peer-reviewed literature — 4 sources cited, last reviewed .